Literature DB >> 19418031

[Two faces of Janus. Coexistence of systemic lupus erythematosus and psoriasis in the same patient].

I Shimanovich1, V Merl, D Zillikens, J Grabbe, C Rose.   

Abstract

While both lupus erythematosus and psoriasis are inflammatory dermatoses characterized by scaly erythematous plaques, they are rarely confused in clinical practice. We report a woman who alternately presented with lupus erythematosus and psoriasis over 14 years but the former condition was not recognized and adequately treated. After the complete diagnosis had been established, a combination of thalidomide and acitretin resulted in a prolonged remission of both disorders. This unusual case demonstrates that coexistence of two diseases in one patient presents a diagnostic challenge that can only be met by repeated careful correlation of all clinical and histopathologic findings. It is of particular importance if these diseases require conflicting management strategies.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 19418031     DOI: 10.1007/s00105-009-1734-0

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  7 in total

1.  Action of synthetic antimalarial drugs on psoriasis.

Authors:  T CORNBLEET
Journal:  J Invest Dermatol       Date:  1956-06       Impact factor: 8.551

2.  High prevalence of systemic lupus erythematosus in 78 myasthenia gravis patients: a clinical and serologic study.

Authors:  Zev Sthoeger; Alexander Neiman; Daniel Elbirt; Hiedy Zinger; Eli Magen; Rimona Burstein; Sara Eitan; Jakov Abarbanel; Edna Mozes
Journal:  Am J Med Sci       Date:  2006-01       Impact factor: 2.378

Review 3.  Inquiry into murine and human lupus.

Authors:  D M Klinman; A D Steinberg
Journal:  Immunol Rev       Date:  1995-04       Impact factor: 12.988

4.  The majority of epidermal T cells in Psoriasis vulgaris lesions can produce type 1 cytokines, interferon-gamma, interleukin-2, and tumor necrosis factor-alpha, defining TC1 (cytotoxic T lymphocyte) and TH1 effector populations: a type 1 differentiation bias is also measured in circulating blood T cells in psoriatic patients.

Authors:  L M Austin; M Ozawa; T Kikuchi; I B Walters; J G Krueger
Journal:  J Invest Dermatol       Date:  1999-11       Impact factor: 8.551

5.  Close relationship between systemic lupus erythematosus and thrombotic thrombocytopenic purpura in childhood.

Authors:  H I Brunner; M Freedman; E D Silverman
Journal:  Arthritis Rheum       Date:  1999-11

6.  Efalizumab in the treatment of discoid lupus erythematosus.

Authors:  Naila Usmani; Mark Goodfield
Journal:  Arch Dermatol       Date:  2007-07

7.  Autoimmune diseases induced by TNF-targeted therapies: analysis of 233 cases.

Authors:  Manuel Ramos-Casals; Pilar Brito-Zerón; Sandra Muñoz; Natalia Soria; Diana Galiana; Laura Bertolaccini; Maria-Jose Cuadrado; Munther A Khamashta
Journal:  Medicine (Baltimore)       Date:  2007-07       Impact factor: 1.889

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.